About Invitrocare Inc.
Invitrocare Inc. is a Pharmaceuticals company, headquartered in Frederick, with 11 - 50 employees and annual revenue of $1M - $5M.
InVitroCare Incorporated provides a complete line of culture media, sperm preparation media, media supplements and ICSI products for Assisted Reproductive Technology - In Vitro Fertilization, Intra Uterine Insemination, and Intracytoplasmic Sperm Injection.
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Invitrocare Inc. Company Highlights
Phone Number
(301) 360-xxxx
Corporate Office Address
8415 Progress Drive
Frederick, 21701
Website
Invitrocare Inc. Org
Invitrocare Inc. has 1 C-Level, 1 VP, and 1 Other employees.
Invitrocare Inc.'s Tech Stack
Frequently Asked Questions About
Invitrocare Inc.
Log in or sign up to get full contact details and additional support.
How many senior employees does Invitrocare Inc. have?
Invitrocare Inc. has 2 senior employees that are typically used for decision making.
What technologies does Invitrocare Inc. use?
Invitrocare Inc. uses technologies including Adobe, Modernizr, and Squarespace.
How do I contact Invitrocare Inc.?
To contact Invitrocare Inc., visit invitrocare.com.
What companies are similar to Invitrocare Inc.?
Companies similar to Invitrocare Inc. include Bristol Myers Squibb, Pharmaceutical Product Development LLC, and PANTHERx Rare Pharmacy.
Where is Invitrocare Inc. headquartered?
Invitrocare Inc. is headquartered at 8415 Progress Drive, Frederick.
What is the main phone number for Invitrocare Inc.?
The main phone number for Invitrocare Inc. is (301) 360-xxxx.
What is the official website for Invitrocare Inc.?
The official website for Invitrocare Inc. is invitrocare.com.
What is the annual revenue of Invitrocare Inc.?
The annual revenue of Invitrocare Inc. is $1M - $5M.
How many employees does Invitrocare Inc. have?
Invitrocare Inc. has 11 - 50 employees.
What industry is Invitrocare Inc. in?
Invitrocare Inc. is in the Pharmaceuticals industry.
Last updated: July 22, 2025